Global Anti-Obesity Prescription Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID :QYR-14142708 | Published Date: 25-Apr-2019 | No. of pages: 131Description
TOC
Table of Contents
1 Anti-Obesity Prescription Market Overview
1.1 Anti-Obesity Prescription Product Overview
1.2 Anti-Obesity Prescription Market Segment by Type
1.2.1 Bupropion and Naltrexone
1.2.2 Orlistat
1.2.3 Lorcaserin
1.2.4 Phentermine and Topiramate
1.2.5 Liraglutide
1.3 Global Anti-Obesity Prescription Market Size by Type
1.3.1 Global Anti-Obesity Prescription Sales and Growth by Type
1.3.2 Global Anti-Obesity Prescription Sales and Market Share by Type (2014-2019)
1.3.3 Global Anti-Obesity Prescription Revenue and Market Share by Type (2014-2019)
1.3.4 Global Anti-Obesity Prescription Price by Type (2014-2019)
2 Global Anti-Obesity Prescription Market Competition by Company
2.1 Global Anti-Obesity Prescription Sales and Market Share by Company (2014-2019)
2.2 Global Anti-Obesity Prescription Revenue and Share by Company (2014-2019)
2.3 Global Anti-Obesity Prescription Price by Company (2014-2019)
2.4 Global Top Players Anti-Obesity Prescription Manufacturing Base Distribution, Sales Area, Product Types
2.5 Anti-Obesity Prescription Market Competitive Situation and Trends
2.5.1 Anti-Obesity Prescription Market Concentration Rate
2.5.2 Global Anti-Obesity Prescription Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Anti-Obesity Prescription Company Profiles and Sales Data
3.1 Zydus Cadila
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Anti-Obesity Prescription Product Category, Application and Specification
3.1.3 Zydus Cadila Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Akrimax Pharmaceuticals
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Anti-Obesity Prescription Product Category, Application and Specification
3.2.3 Akrimax Pharmaceuticals Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Zealand Pharma
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Anti-Obesity Prescription Product Category, Application and Specification
3.3.3 Zealand Pharma Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Arrowhead Research
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Anti-Obesity Prescription Product Category, Application and Specification
3.4.3 Arrowhead Research Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Arena Pharmaceuticals
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Anti-Obesity Prescription Product Category, Application and Specification
3.5.3 Arena Pharmaceuticals Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Compellis Pharmaceuticals
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Anti-Obesity Prescription Product Category, Application and Specification
3.6.3 Compellis Pharmaceuticals Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Yungjin Pharm
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Anti-Obesity Prescription Product Category, Application and Specification
3.7.3 Yungjin Pharm Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Alpex Pharma
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Anti-Obesity Prescription Product Category, Application and Specification
3.8.3 Alpex Pharma Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Bridge BioResearch
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Anti-Obesity Prescription Product Category, Application and Specification
3.9.3 Bridge BioResearch Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
4 Anti-Obesity Prescription Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Anti-Obesity Prescription Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Anti-Obesity Prescription Sales and Revenue by Regions
4.2.1 Global Anti-Obesity Prescription Sales and Market Share by Regions (2014-2019)
4.2.2 Global Anti-Obesity Prescription Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Anti-Obesity Prescription Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Anti-Obesity Prescription Application/End Users
5.1 Anti-Obesity Prescription Segment by Application
5.1.1 Hospital Pharmacies
5.1.2 Retail Pharmacies
5.1.3 E-Commerce
5.2 Global Anti-Obesity Prescription Product Segment by Application
5.2.1 Global Anti-Obesity Prescription Sales by Application
5.2.2 Global Anti-Obesity Prescription Sales and Market Share by Application (2014-2019)
6 Global Anti-Obesity Prescription Market Forecast
6.1 Global Anti-Obesity Prescription Sales, Revenue Forecast (2019-2025)
6.1.1 Global Anti-Obesity Prescription Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Anti-Obesity Prescription Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Anti-Obesity Prescription Forecast by Regions
6.2.1 North America Anti-Obesity Prescription Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Anti-Obesity Prescription Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Anti-Obesity Prescription Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Anti-Obesity Prescription Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Anti-Obesity Prescription Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Anti-Obesity Prescription Forecast by Type
6.3.1 Global Anti-Obesity Prescription Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Bupropion and Naltrexone Gowth Forecast
6.3.3 Orlistat Gowth Forecast
6.4 Anti-Obesity Prescription Forecast by Application
6.4.1 Global Anti-Obesity Prescription Sales Forecast by Application (2019-2025)
6.4.2 Global Anti-Obesity Prescription Forecast in Hospital Pharmacies
6.4.3 Global Anti-Obesity Prescription Forecast in Retail Pharmacies
7 Anti-Obesity Prescription Upstream Raw Materials
7.1 Anti-Obesity Prescription Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Anti-Obesity Prescription Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
Tables & Figures
List of Tables and Figures
Figure Anti-Obesity Prescription Product Picture
Figure Global Anti-Obesity Prescription Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Anti-Obesity Prescription Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of Bupropion and Naltrexone
Table Major Players of Bupropion and Naltrexone
Figure Global Bupropion and Naltrexone Sales (K Units) and Growth Rate (%)(2014-2018)
Figure Product Picture of Orlistat
Table Major Players of Orlistat
Figure Global Orlistat Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Lorcaserin
Table Major Players of Lorcaserin
Figure Global Lorcaserin Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Phentermine and Topiramate
Table Major Players of Phentermine and Topiramate
Figure Global Phentermine and Topiramate Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Liraglutide
Table Major Players of Liraglutide
Figure Global Liraglutide Sales (K Units) and Growth Rate (%)(2014-2019)
Table Global Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Comparison by Type
Table Global Anti-Obesity Prescription Sales (K Units) by Type (2014-2019)
Table Global Anti-Obesity Prescription Sales Share (%) by Type (2014-2019)
Figure Global Anti-Obesity Prescription Sales Market Share (%) by Type (2014-2019)
Figure Global Anti-Obesity Prescription Sales Market Share (%) by Type in 2018
Table Global Anti-Obesity Prescription Revenue (Million USD) by Type (2014-2019)
Table Global Anti-Obesity Prescription Revenue Share (%) by Type (2014-2019)
Figure Global Anti-Obesity Prescription Revenue Share (%) by Type (2014-2019)
Figure 2018 Global Anti-Obesity Prescription Revenue Market Share (%) by Type
Table Global Anti-Obesity Prescription Price (USD/Unit) by Type (2014-2019)
Table Global Anti-Obesity Prescription Sales (K Units) by Company (2014-2019)
Table Global Anti-Obesity Prescription Sales Share (%) by Company (2014-2019)
Figure Global Anti-Obesity Prescription Sales Share (%) by Company in 2018
Table Global Anti-Obesity Prescription Revenue (Million USD) by Company (2014-2019)
Table Global Anti-Obesity Prescription Revenue Share (%) by Company (2014-2019)
Figure Global Anti-Obesity Prescription Revenue Share (%) by Company in 2018
Table Global Market Anti-Obesity Prescription Average Price (USD/Unit) by Company (2014-2019)
Table Global Anti-Obesity Prescription Top Players Manufacturing Base Distribution and Sales Area
Table Global Anti-Obesity Prescription Top Players Product Category
Figure Global Anti-Obesity Prescription Market Share (%) of Top 5 Players
Figure Global Anti-Obesity Prescription Market Share (%) of Top 10 Players
Table Zydus Cadila Basic Information List
Table Zydus Cadila Anti-Obesity Prescription Product Category, Application and Specification
Table Zydus Cadila Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Zydus Cadila Anti-Obesity Prescription Sales Growth Rate (2014-2019)
Figure Zydus Cadila Anti-Obesity Prescription Sales Global Market Share (%)(2014-2019)
Table Akrimax Pharmaceuticals Basic Information List
Figure Akrimax Pharmaceuticals Anti-Obesity Prescription Product Category, Application and Specification
Table Akrimax Pharmaceuticals Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Akrimax Pharmaceuticals Anti-Obesity Prescription Sales Growth Rate (2014-2019)
Figure Akrimax Pharmaceuticals Anti-Obesity Prescription Sales Global Market Share (%)(2014-2019)
Table Zealand Pharma Basic Information List
Figure Zealand Pharma Anti-Obesity Prescription Product Category, Application and Specification
Table Zealand Pharma Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Zealand Pharma Anti-Obesity Prescription Sales Growth Rate (2014-2019)
Figure Zealand Pharma Anti-Obesity Prescription Sales Global Market Share (%)(2014-2019)
Table Arrowhead Research Basic Information List
Figure Arrowhead Research Anti-Obesity Prescription Product Category, Application and Specification
Table Arrowhead Research Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Arrowhead Research Anti-Obesity Prescription Sales Growth Rate (2014-2019)
Figure Arrowhead Research Anti-Obesity Prescription Sales Global Market Share (%)(2014-2019)
Table Arena Pharmaceuticals Basic Information List
Figure Arena Pharmaceuticals Anti-Obesity Prescription Product Category, Application and Specification
Table Arena Pharmaceuticals Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Arena Pharmaceuticals Anti-Obesity Prescription Sales Growth Rate (2014-2019)
Figure Arena Pharmaceuticals Anti-Obesity Prescription Sales Global Market Share (%)(2014-2019)
Table Compellis Pharmaceuticals Basic Information List
Figure Compellis Pharmaceuticals Anti-Obesity Prescription Product Category, Application and Specification
Table Compellis Pharmaceuticals Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Compellis Pharmaceuticals Anti-Obesity Prescription Sales Growth Rate (2014-2019)
Figure Compellis Pharmaceuticals Anti-Obesity Prescription Sales Global Market Share (%)(2014-2019)
Table Yungjin Pharm Basic Information List
Figure Yungjin Pharm Anti-Obesity Prescription Product Category, Application and Specification
Table Yungjin Pharm Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Yungjin Pharm Anti-Obesity Prescription Sales Growth Rate (2014-2019)
Figure Yungjin Pharm Anti-Obesity Prescription Sales Global Market Share (%)(2014-2019)
Table Alpex Pharma Basic Information List
Figure Alpex Pharma Anti-Obesity Prescription Product Category, Application and Specification
Table Alpex Pharma Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Alpex Pharma Anti-Obesity Prescription Sales Growth Rate (2014-2019)
Figure Alpex Pharma Anti-Obesity Prescription Sales Global Market Share (%)(2014-2019)
Table Bridge BioResearch Basic Information List
Figure Bridge BioResearch Anti-Obesity Prescription Product Category, Application and Specification
Table Bridge BioResearch Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Bridge BioResearch Anti-Obesity Prescription Sales Growth Rate (2014-2019)
Figure Bridge BioResearch Anti-Obesity Prescription Sales Global Market Share (%)(2014-2019)
Table Global Anti-Obesity Prescription Market Size Comparison by Regions (2014-2025)
Figure North America Anti-Obesity Prescription Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific Anti-Obesity Prescription Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe Anti-Obesity Prescription Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America Anti-Obesity Prescription Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa Anti-Obesity Prescription Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global Anti-Obesity Prescription Sales (K Units) by Regions (2014-2019)
Table Global Anti-Obesity Prescription Sales Market Share (%) by Regions (2014-2019)
Figure Global Anti-Obesity Prescription Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global Anti-Obesity Prescription Sales Market Share (%) by Regions
Table Global Anti-Obesity Prescription Revenue (Million USD) by Regions (2014-2019)
Table Global Anti-Obesity Prescription Revenue Market Share (%) by Regions (2014-2019)
Figure Global Anti-Obesity Prescription Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global Anti-Obesity Prescription Revenue Market Share (%) by Regions
Table Global Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North America Anti-Obesity Prescription Sales Growth Rate
Table North America Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure United States Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure United States Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Canada Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Canada Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Mexico Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Mexico Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Europe Anti-Obesity Prescription Sales Growth Rate
Table Europe Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Germany Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Germany Anti-Obesity Prescription Revenue (Million USD) (2014-2019)
Figure UK Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure UK Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure France Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure France Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Italy Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Italy Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Russia Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Russia Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Turkey Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Turkey Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Anti-Obesity Prescription Sales Growth Rate
Table Asia-Pacific Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure China Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure China Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Japan Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Japan Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Korea Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Korea Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Southeast Asia Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Southeast Asia Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Indonesia Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Indonesia Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Thailand Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Thailand Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Malaysia Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Malaysia Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Philippines Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Philippines Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Vietnam Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Vietnam Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure India Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure India Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Australia Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Australia Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure South America Anti-Obesity Prescription Sales Growth Rate
Table South America Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Brazil Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure Brazil Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Middle East and Africa Anti-Obesity Prescription Sales Growth Rate
Table Middle East and Africa Anti-Obesity Prescription Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North Africa Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure North Africa Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure GCC Countries Anti-Obesity Prescription Sales (K Units)(2014-2019)
Figure GCC Countries Anti-Obesity Prescription Revenue (Million USD)(2014-2019)
Figure Hospital Pharmacies Examples
Figure Retail Pharmacies Examples
Figure E-Commerce Examples
Table Global Anti-Obesity Prescription Sales (K Units) Comparison by Application (2014-2025)
Table Global Anti-Obesity Prescription Sales (K Units) by Application (2014-2019)
Table Global Anti-Obesity Prescription Sales Share (%) by Application (2014-2019)
Figure Global Anti-Obesity Prescription Sales Market Share (%) by Application (2014-2019)
Figure Global Anti-Obesity Prescription Sales Market Share (%) by Application in 2018
Figure Global Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Global Anti-Obesity Prescription Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Anti-Obesity Prescription Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Anti-Obesity Prescription Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North America Anti-Obesity Prescription Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Anti-Obesity Prescription Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Anti-Obesity Prescription Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure China Anti-Obesity Prescription Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Japan Anti-Obesity Prescription Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Korea Anti-Obesity Prescription Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Anti-Obesity Prescription Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure India Anti-Obesity Prescription Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Australia Anti-Obesity Prescription Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure South America Anti-Obesity Prescription Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Anti-Obesity Prescription Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Anti-Obesity Prescription Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Anti-Obesity Prescription Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Anti-Obesity Prescription Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global Anti-Obesity Prescription Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Anti-Obesity Prescription Sales Market Share (%) Forecast by Type (2019-2025)
Table Global Anti-Obesity Prescription Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Anti-Obesity Prescription Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Bupropion and Naltrexone Sales Growth Forecast
Figure Orlistat Sales Growth Forecast
Table Global Anti-Obesity Prescription Sales (K Units) Forecast by Application (2019-2025)
Figure Global Anti-Obesity Prescription Sales Forecast by Application (2019-2025)
Figure Global Anti-Obesity Prescription Sales (K Units) Forecast in Hospital Pharmacies
Figure Global Anti-Obesity Prescription Sales (K Units) Forecast in Retail Pharmacies
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Anti-Obesity Prescription Manufacturing Cost Structure
Figure Anti-Obesity Prescription Industrial Chain Analysis
Table Distributors List
Table Anti-Obesity Prescription Downstream Customers
Companies
Zydus Cadila
Akrimax Pharmaceuticals
Zealand Pharma
Arrowhead Research
Arena Pharmaceuticals
Compellis Pharmaceuticals
Yungjin Pharm
Alpex Pharma
Bridge BioResearch
- PRICE
-
$3350$6700$5025Buy Now